The microenvironment in hairy cell leukemia: pathways and potential therapeutic targets

Jan A Burger1, Mariela Sivina, Farhad Ravandi

  • 1Department of Leukemia, The University of Texas M D Anderson Cancer Center, Houston, TX 77230-1402, USA. jaburger@mdanderson.org

Leukemia & Lymphoma
|March 29, 2011
PubMed

Insights

Hairy cell leukemia cells interact with their microenvironment, crucial for survival and proliferation. Targeting these interactions, including chemokine receptors and B cell receptor signaling, offers new therapeutic strategies for HCL.

Area of Science:

  • Hematology
  • Oncology
  • Cell Biology

Background:

  • Hairy cell leukemia (HCL) is characterized by neoplastic B cell accumulation in the spleen and bone marrow.
  • HCL cells interact with the surrounding microenvironment, involving accessory cells, matrix proteins, and cytokines.
  • Surface receptors on HCL cells mediate critical cross-talk with their microenvironment, influencing cell behavior.

Purpose of the Study:

  • To summarize key cellular and molecular interactions between HCL cells and their microenvironment.
  • To outline future therapeutic strategies targeting the HCL microenvironment.

Main Methods:

  • Review of literature on HCL cell-microenvironment interactions.
  • Focus on surface receptors like chemokine receptors, adhesion molecules, B cell antigen receptor (BCR), and CD40.
  • Discussion of potential therapeutic targets including CXCR4 and kinase inhibitors.

Main Results:

  • Identified critical roles for surface receptors (e.g., CXCR4, BCR signaling components) in HCL cell homing, retention, survival, and expansion.
  • Highlighted the significance of microenvironmental interactions for HCL pathogenesis.
  • Noted that similar pathways are being targeted in other mature B-cell malignancies.

Conclusions:

  • The microenvironment plays a pivotal role in hairy cell leukemia.
  • Targeting specific pathways, such as CXCR4 and B cell receptor signaling (Syk, Btk, PI3K), presents promising therapeutic avenues for HCL.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...